Cost-utility analysis of genomic profiling in early breast cancer in Colombia

被引：0
|
作者：
Leonardo Rojas
María X. Rojas-Reyes
Diego Rosselli
Juan Guillermo Ariza
Alejandro Ruiz-Patiño
Andrés F. Cardona
机构：
[1] Thoracic and GU Unit,Molecular Oncology and Biology Systems Research Group (Fox
[2] Fundación Centro de Tratamiento en Investigación Sobre Cáncer Luis Carlos Sarmiento Angulo (CTIC),G)
[3] Universidad El Bosque,Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine
[4] Institut d´Investigació Biomédica Sant Pau (IIB SANT PAU),Head Medical Affairs
[5] Pontificia Universidad Javeriana,Direction of Research, Science and Education
[6] Baxter International,undefined
[7] Foundation for Clinical and Applied Cancer Research-FICMAC,undefined
[8] Fundación Centro de Tratamiento en Investigación Sobre Cáncer Luis Carlos Sarmiento Angulo (CTIC),undefined
来源：
Cost Effectiveness and Resource Allocation | / 21卷
关键词：
Breast cancer; Personalized medicine; Cost-utility;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cost-utility analysis of genomic profiling in early breast cancer in Colombia
    Rojas, Leonardo
    Rojas-Reyes, Maria X.
    Rosselli, Diego
    Ariza, Juan Guillermo
    Ruiz-Patino, Alejandro
    Cardona, Andres F.
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
  • [2] Palbociclib in advanced breast cancer: A cost-utility analysis
    Raphael, J.
    Helou, J.
    Naimark, D. M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [3] COST-UTILITY ANALYSIS OF ADJUVANT THERAPIES FOR BREAST CANCER IN IRAN
    Bastani, Peivand
    Kiadaliri, Aliasghar Ahmed
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (02) : 110 - 114
  • [4] Cost-utility analysis of a palliative care program in Colombia
    Rodriguez-Campos, Luisa
    Rodriguez-Lesmes, Paul Andres
    Cancino, Analhi Palomino
    Diaz, Iris del Valle
    Gamboa, Luis Fernando
    Niuman, Andrea Castillo
    Salas, Juan Sebastian
    Sarmiento, Gabriela
    Martinez-Bernal, Jorge
    Gonzalez-Velez, Abel E.
    [J]. BMC PALLIATIVE CARE, 2024, 23 (01):
  • [5] COST-UTILITY ANALYSIS OF CANCER CARE
    OESER, H
    KOEPPE, P
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1984, 126 (09): : A38 - &
  • [6] A cost-utility analysis of Fulvestrant in treating recurrent metastatic breast cancer
    Park, S. Y.
    Kang, H. H.
    Noh, E.
    Lee, E. K.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A71 - A71
  • [7] Liver Resection for Breast Cancer Liver Metastases A Cost-utility Analysis
    Spolverato, Gaya
    Vitale, Alessandro
    Bagante, Fabio
    Connolly, Roisin
    Pawlik, Timothy M.
    [J]. ANNALS OF SURGERY, 2017, 265 (04) : 792 - 799
  • [8] COST-UTILITY MODEL TO EVALUATE ADJUVANT CHEMOTHERAPY FOR EARLY BREAST CANCER IN THE USA
    Wolowacz, S. E.
    Jhaveri, M.
    Tangirala, M.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A279 - A279
  • [9] COST-UTILITY ANALYSIS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA IN COLOMBIA
    Ordonez, J.
    Ordonez, A.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S360 - S361
  • [10] Cost-utility analysis of 21-gene assay for node-positive early breast cancer
    Masucci, L.
    Torres, S.
    Eisen, A.
    Trudeau, M.
    Tyono, I
    Saunders, H.
    Chan, K. W.
    Isaranuwatchai, W.
    [J]. CURRENT ONCOLOGY, 2019, 26 (05) : 307 - 318
12345